Insights

Regulatory digitization Targeted expansion into regulated biotech labs and cell therapy manufacturers should emphasize converting paper-based production reports into digital GMP workflows, positioning MyCellHub as a time-saving, compliance-enabling solution for faster therapy development.

MES integration Highlight opportunities with companies seeking manufacturing execution system capabilities, especially those looking to streamline data capture, batch traceability, and real-time analytics in small to mid-sized biopharma or contract manufacturing organizations.

Acquisition signal The January 2026 acquisition by Title21 Health Solutions signals a validation of the platform; approach similar scale players and MES/quality management providers with co-sell offers or integration partnerships to access a larger customer base.

Funding momentum Leverage the €1M funding history and ongoing growth potential to justify ROI with potential customers, particularly in universities, research labs, and start-ups seeking accelerator-fit digital tooling to accelerate therapy development and regulatory submissions.

Low headcount, high leverage With a small team, position MyCellHub as a lightweight, fast-implementing solution that can be deployed with minimal training and quick time-to-value for biotech startups and niche CROs needing rapid digital workflow adoption.

Similar companies to MyCellHub

MyCellHub Tech Stack

MyCellHub uses 8 technology products and services including HubSpot Analytics, Amazon Web Services, WordPress, and more. Explore MyCellHub's tech stack below.

MyCellHub's Email Address Formats

MyCellHub uses at least 3 email formats:
MyCellHub Email FormatsExamplePercentage
First.Last@mycellhub.comJohn.Doe@mycellhub.com
66%
First@mycellhub.comJohn@mycellhub.com
31%
First.MiddleLast@mycellhub.comJohn.MichaelDoe@mycellhub.com
3%

Frequently Asked Questions

What is MyCellHub's official website and social media links?

Minus sign iconPlus sign icon
MyCellHub's official website is mycellhub.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does MyCellHub generate?

Minus sign iconPlus sign icon
As of November 2026, MyCellHub's annual revenue is estimated to be $1M - $10M.

What is MyCellHub's SIC code and NAICS code?

Minus sign iconPlus sign icon
MyCellHub's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does MyCellHub have currently?

Minus sign iconPlus sign icon
As of November 2026, MyCellHub has approximately 4 employees across 1 continents, including Europe. Key team members include Cto Ad-Interim: N. L., Co-Founder, Chief Customer Success Officer: S. D. B. and Project Manager: A. H. Explore MyCellHub's employee directory with LeadIQ.

What industry does MyCellHub belong to?

Minus sign iconPlus sign icon
MyCellHub operates in the Biotechnology Research industry.

What technology does MyCellHub use?

Minus sign iconPlus sign icon
MyCellHub's tech stack includes HubSpot Analytics, Amazon Web Services, WordPress, Google Workspace, Mailgun, Microsoft 365, Notion and Webflow.

What is MyCellHub's email format?

Minus sign iconPlus sign icon
MyCellHub's email format typically follows the pattern of First.Last@mycellhub.com. Find more MyCellHub email formats with LeadIQ.

How much funding has MyCellHub raised to date?

Minus sign iconPlus sign icon
As of November 2026, MyCellHub has raised $3.3M in funding. The last funding round occurred on Dec 15, 2022 for $2.1M.

When was MyCellHub founded?

Minus sign iconPlus sign icon
MyCellHub was founded in 2019.
MyCellHub logo

MyCellHub

Biotechnology ResearchFlanders, Belgium2-10 Employees

Based in Hasselt, Flanders, MyCellHub operates in the biotechnology research sector, offering a toolkit to digitalize, integrate data, and analyze regulated laboratory and cleanroom workflows. The platform supports transforming production reporting away from paper toward digital processes, addressing a common dependency on paper documentation in biotech and biopharmaceutical manufacturing. By enabling digital GMP workflows, the company aims to speed therapeutic development by reducing administrative bottlenecks and enabling faster data-driven decisions. Its target customers are biotech and biopharmaceutical firms that run regulated lab environments and seek to improve data capture and analytics across manufacturing processes. The company positions itself within the regulated biotech manufacturing space, supplying tools to manage digital GMP processes and data integration for compliance. In January 2026, MyCellHub was acquired by Title21 Software, Inc., a Phoenix, Arizona-based provider of enterprise quality management systems and cell and gene therapy orchestration platforms, which also includes its advanced manufacturing execution system platform.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2019
Employees
2-10

Section iconFunding & Financials

  • $3.3M

    MyCellHub has raised a total of $3.3M of funding over 2 rounds. Their latest funding round was raised on Dec 15, 2022 in the amount of $2.1M as a Venture Round.

  • $1M - $10M

    MyCellHub's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.